These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8445737)

  • 21. Regulation of GM-CSF gene transcription by core-binding factor.
    Cockerill PN; Osborne CS; Bert AG; Grotto RJ
    Cell Growth Differ; 1996 Jul; 7(7):917-22. PubMed ID: 8809409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
    Ethelberg S; Hallberg B; Lovmand J; Schmidt J; Luz A; Grundström T; Pedersen FS
    J Virol; 1997 Feb; 71(2):1196-206. PubMed ID: 8995642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of reversions and suppressors of a mutation in the CBF binding site of a lymphomagenic retrovirus.
    Martiney MJ; Rulli K; Beaty R; Levy LS; Lenz J
    J Virol; 1999 Sep; 73(9):7599-606. PubMed ID: 10438850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct roles for c-Myb and core binding factor/polyoma enhancer-binding protein 2 in the assembly and function of a multiprotein complex on the TCR delta enhancer in vivo.
    Hernández-Munain C; Krangel MS
    J Immunol; 2002 Oct; 169(8):4362-9. PubMed ID: 12370369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression.
    Perkins ND; Agranoff AB; Duckett CS; Nabel GJ
    J Virol; 1994 Oct; 68(10):6820-3. PubMed ID: 8084021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
    Manley NR; O'Connell MA; Sharp PA; Hopkins N
    J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A DNA element responsible for the different tissue specificities of Friend and Moloney retroviral enhancers.
    Thiesen HJ; Bösze Z; Henry L; Charnay P
    J Virol; 1988 Feb; 62(2):614-8. PubMed ID: 2826819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
    Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
    J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the transcriptional properties of the Friend and Moloney retrovirus long terminal repeats: importance of tandem duplications and of the core enhancer sequence.
    Clark SP; Kaufhold R; Chan A; Mak TW
    Virology; 1985 Jul; 144(2):481-94. PubMed ID: 4060594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
    Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
    J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.
    Zaiman AL; Lenz J
    J Virol; 1996 Aug; 70(8):5618-29. PubMed ID: 8764076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single mutation in one of the CORE elements of Moloney murine leukemia virus reduced binding of a 42-kDa T lymphoma cell nuclear factor but did not affect lymphomagenesis.
    Case RS; Khang YH; Kumar A; Yuen PH
    Mol Carcinog; 1990; 3(2):93-102. PubMed ID: 2346587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The DNA-binding domain of HPV-16 E2 protein interaction with the viral enhancer: protein-induced DNA bending and role of the nonconserved core sequence in binding site affinity.
    Bedrosian CL; Bastia D
    Virology; 1990 Feb; 174(2):557-75. PubMed ID: 2154890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.
    Feuer G; Taketo M; Hanecak RC; Fan H
    J Virol; 1989 May; 63(5):2317-24. PubMed ID: 2704078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single point mutation activates the Moloney murine leukemia virus long terminal repeat in embryonal stem cells.
    Grez M; Zörnig M; Nowock J; Ziegler M
    J Virol; 1991 Sep; 65(9):4691-8. PubMed ID: 1870196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions.
    Giese K; Kingsley C; Kirshner JR; Grosschedl R
    Genes Dev; 1995 Apr; 9(8):995-1008. PubMed ID: 7774816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A protein-binding site with dyad symmetry in the long terminal repeat of the MCF13 murine leukemia virus that contributes to transcriptional activity in T lymphocytes.
    Yoshimura FK; Diem K; Chen H; Tupper J
    J Virol; 1993 Apr; 67(4):2298-304. PubMed ID: 8383242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region.
    Jackson ME; Campo MS
    J Virol; 1995 Oct; 69(10):6038-46. PubMed ID: 7666508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-DNA interactions in vivo of an erythroid-specific, human beta-globin locus enhancer.
    Reddy PM; Shen CK
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8676-80. PubMed ID: 1924329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Slipped DNA structures within the enhancer region of the Moloney murine leukemia virus.
    Gama Sosa MA; Hall JC; Ruprecht RM
    Biochem Biophys Res Commun; 1988 Oct; 156(1):417-23. PubMed ID: 3052452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.